AMY SCANLON: Open Payments
NPI 1922426717 · DEPTFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,959 in 172 payments from 25 companies in 2025. Trend: 2023 $3,200 · 2024 $2,768 · 2025 $2,959
Food & beverage: $2,901Education: $58
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 42 | $473 |
| Mannkind Corporation | 14 | $321 |
| Ascendis Pharma Endocrinology Inc | 15 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $246 |
| Novo Nordisk Inc | 14 | $214 |
| RECORDATI_RARE_DISEASES_INC. | 13 | $182 |
| Amgen Inc. | 11 | $181 |
| Amneal Pharmaceuticals LLC | 8 | $155 |
| Xeris Pharmaceuticals, Inc. | 5 | $94 |
| Lilly USA, LLC | 5 | $92 |
Products named: Omnipod, AFREZZA, Yorvipath, Kerendia, ISTURISA, UNITHROID, RECORLEV, Wegovy.
Industry payments across NJ — which companies pay providers there.
